603983.SS SHH
Guangdong Marubi Biotechnology Co., Ltd.
1W: -3.7%
1M: +8.1%
3M: +12.1%
YTD: -5.9%
1Y: -23.7%
3Y: +12.3%
5Y: -38.3%
¥30.86 ($4.60)
+0.46 (+1.51%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$301M
-11.1% ▼
5Y CAGR: -8.4%
Capital Expenditures
$316M
-24.5% ▼
5Y CAGR: +118.0%
Free Cash Flow
-$16M
-118.9% ▼
Dividends Paid
$313M
-195.1% ▼
Buybacks
$0
+100.0% ▲
Net Change in Cash
$540M
+2504.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $463M | $241M | $167M | $259M | $342M |
| Depreciation & Amort. | $13M | $20M | $27M | $25M | $30M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$111M | -$269M | -$138M | $133M | -$40M |
| Other Non-Cash Items | -$3M | $245K | -$7M | -$79M | -$32M |
| Operating Cash Flow | $362M | -$7M | $48M | $338M | $301M |
| — Investing Activities — | |||||
| Capital Expenditures | -$749M | -$117M | -$111M | -$254M | -$321M |
| Acquisitions (Net) | $18K | $2M | $9M | $0 | $2M |
| Investment Purchases | -$3.3B | -$2.1B | -$287M | -$425M | -$595M |
| Investment Sales | $3.2B | $2.2B | $597M | $218M | $843M |
| Other Investing | $0 | -$634M | -$138M | $246M | $504M |
| Investing Cash Flow | -$782M | -$681M | $70M | -$215M | $432M |
| — Financing Activities — | |||||
| Net Debt Issuance | $107M | -$4M | $150M | $89M | -$98M |
| Stock Repurchased | $0 | -$4M | -$9M | -$13M | $0 |
| Dividends Paid | -$157M | -$142M | -$76M | -$106M | -$313M |
| Other Financing | $25M | -$23M | $72M | -$104M | $218M |
| Financing Cash Flow | -$25M | -$170M | $145M | -$135M | -$193M |
| Net Change in Cash | -$445M | -$858M | $263M | -$22M | $540M |
| Cash End of Period | $1.7B | $799M | $1.1B | $1.0B | $1.6B |
| Free Cash Flow | -$387M | -$125M | -$62M | $84M | -$16M |